Oppenheimer Maintains Outperform Rating on Xylem, Keeps $135 Target
Oppenheimer maintained its Outperform rating on Xylem and a $135 price target. The target implies 45.4% upside from the Oct. 27 close of $92.86.
Story updates
12:53:39 PM UTC
SquawkNews
08:49 AM EDT, 10/28/2026 (MT Newswires) -- Xylem (XYL) has an average rating of overweight and mean
12:55:46 PM UTC
SquawkNews
Xylem Price Target Cut to $135.00/Share From $150.00 by Oppenheimer